0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pertussis Vaccine Market Insights, Forecast to 2025
Published Date: May 2019
|
Report Code: QYRE-Auto-7141
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Pertussis Vaccine Market Insights Forecast to 2025

Global Pertussis Vaccine Market Insights, Forecast to 2025

Code: QYRE-Auto-7141
Report
May 2019
116 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
Manufacturers take the combination of direct Marketing channel and distribution sales in the form, Future sales channels both direct selling and distribution needs with the help of online sales platform. The market channel is essential to every manufacturer and they are paying more and more attention to their channel building. Firstly, suppliers can build strong sales teams to directly manage their own customers. At the same time, more flexible and attractive channel incentives can be created and channel support can be provided in different ways. At the meantime, customers are concerning more on the product quality and services. So, except all of the distributors and direct marketing, they are also consider their logistics and services, making sure that both products and services are better than the competitors.
Depending on market position, make different pricing strategy. Pricing product is based on product position. Different kind of dispensers should be priced differently. It is obvious that high-end product should be expensive and low-end product should be cheap. For the manufacturers, depreciate can bring more consumers and inflation can bring larger profit margin. When manufacturers price their products, should consider many factors like the manufacturing cost, market position and targets of price adjustment (larger profit margin, more consumers, larger market share, more order, etc.). To build a brand admired by consumers need a long time, though the period is much shorter due to the development of advertising industry and internet. There are many ways to build a new brand, but only one way is always here, good product quality. Today, brand strategy has been various. Some manufacturers hold their unique brand, which have been acquired by consumers. Exactly, consumers may prefer the known brand rather a new brand that they doesn’t know. On the contrary, some manufacturers may introduce several brands of their product. They featured each brand and market them for certain target client.
The global Pertussis Vaccine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pertussis Vaccine market based on company, product type, end user and key regions.

This report studies the global market size of Pertussis Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pertussis Vaccine in these regions.
This research report categorizes the global Pertussis Vaccine market by top players/brands, region, type and end user. This report also studies the global Pertussis Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
    Sanofi Pasteur
    GSK
    Mitsubishi Tanabe Pharma
    Astellas Pharma
    Minhai Biotechnology
    Wuhan Institute of Biological Products
    Changchun Changsheng Life Sciences

Market size by Product
    Whole-cell vaccines
    Acellular vaccines
Market size by End User
    Children
    Adults

Market size by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Pertussis Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
    To understand the structure of Pertussis Vaccine market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Pertussis Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
    To project the value and sales volume of Pertussis Vaccine submarkets, with respect to key regions.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Pertussis Vaccine are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pertussis Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
    1.1 Pertussis Vaccine Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Pertussis Vaccine Market Size Growth Rate by Product
        1.4.2 Whole-cell vaccines
        1.4.3 Acellular vaccines
    1.5 Market by End User
        1.5.1 Global Pertussis Vaccine Market Size Growth Rate by End User
        1.5.2 Children
        1.5.3 Adults
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Pertussis Vaccine Market Size
        2.1.1 Global Pertussis Vaccine Revenue 2014-2025
        2.1.2 Global Pertussis Vaccine Sales 2014-2025
    2.2 Pertussis Vaccine Growth Rate by Regions
        2.2.1 Global Pertussis Vaccine Sales by Regions
        2.2.2 Global Pertussis Vaccine Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Pertussis Vaccine Sales by Manufacturers
        3.1.1 Pertussis Vaccine Sales by Manufacturers
        3.1.2 Pertussis Vaccine Sales Market Share by Manufacturers
        3.1.3 Global Pertussis Vaccine Market Concentration Ratio (CR5 and HHI)
    3.2 Pertussis Vaccine Revenue by Manufacturers
        3.2.1 Pertussis Vaccine Revenue by Manufacturers (2014-2019)
        3.2.2 Pertussis Vaccine Revenue Share by Manufacturers (2014-2019)
    3.3 Pertussis Vaccine Price by Manufacturers
    3.4 Pertussis Vaccine Manufacturing Base Distribution, Product Types
        3.4.1 Pertussis Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Pertussis Vaccine Product Type
        3.4.3 Date of International Manufacturers Enter into Pertussis Vaccine Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
    4.1 Global Pertussis Vaccine Sales by Product
    4.2 Global Pertussis Vaccine Revenue by Product
    4.3 Pertussis Vaccine Price by Product

5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Pertussis Vaccine Breakdown Data by End User

6 North America
    6.1 North America Pertussis Vaccine by Countries
        6.1.1 North America Pertussis Vaccine Sales by Countries
        6.1.2 North America Pertussis Vaccine Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Pertussis Vaccine by Product
    6.3 North America Pertussis Vaccine by End User

7 Europe
    7.1 Europe Pertussis Vaccine by Countries
        7.1.1 Europe Pertussis Vaccine Sales by Countries
        7.1.2 Europe Pertussis Vaccine Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Pertussis Vaccine by Product
    7.3 Europe Pertussis Vaccine by End User

8 Asia Pacific
    8.1 Asia Pacific Pertussis Vaccine by Countries
        8.1.1 Asia Pacific Pertussis Vaccine Sales by Countries
        8.1.2 Asia Pacific Pertussis Vaccine Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Pertussis Vaccine by Product
    8.3 Asia Pacific Pertussis Vaccine by End User

9 Central & South America
    9.1 Central & South America Pertussis Vaccine by Countries
        9.1.1 Central & South America Pertussis Vaccine Sales by Countries
        9.1.2 Central & South America Pertussis Vaccine Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Pertussis Vaccine by Product
    9.3 Central & South America Pertussis Vaccine by End User

10 Middle East and Africa
    10.1 Middle East and Africa Pertussis Vaccine by Countries
        10.1.1 Middle East and Africa Pertussis Vaccine Sales by Countries
        10.1.2 Middle East and Africa Pertussis Vaccine Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Pertussis Vaccine by Product
    10.3 Middle East and Africa Pertussis Vaccine by End User

11 Company Profiles
    11.1 Sanofi Pasteur
        11.1.1 Sanofi Pasteur Company Details
        11.1.2 Company Business Overview
        11.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue and Gross Margin (2014-2019)
        11.1.4 Sanofi Pasteur Pertussis Vaccine Products Offered
        11.1.5 Sanofi Pasteur Recent Development
    11.2 GSK
        11.2.1 GSK Company Details
        11.2.2 Company Business Overview
        11.2.3 GSK Pertussis Vaccine Sales, Revenue and Gross Margin (2014-2019)
        11.2.4 GSK Pertussis Vaccine Products Offered
        11.2.5 GSK Recent Development
    11.3 Mitsubishi Tanabe Pharma
        11.3.1 Mitsubishi Tanabe Pharma Company Details
        11.3.2 Company Business Overview
        11.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2014-2019)
        11.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Products Offered
        11.3.5 Mitsubishi Tanabe Pharma Recent Development
    11.4 Astellas Pharma
        11.4.1 Astellas Pharma Company Details
        11.4.2 Company Business Overview
        11.4.3 Astellas Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2014-2019)
        11.4.4 Astellas Pharma Pertussis Vaccine Products Offered
        11.4.5 Astellas Pharma Recent Development
    11.5 Minhai Biotechnology
        11.5.1 Minhai Biotechnology Company Details
        11.5.2 Company Business Overview
        11.5.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2014-2019)
        11.5.4 Minhai Biotechnology Pertussis Vaccine Products Offered
        11.5.5 Minhai Biotechnology Recent Development
    11.6 Wuhan Institute of Biological Products
        11.6.1 Wuhan Institute of Biological Products Company Details
        11.6.2 Company Business Overview
        11.6.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2014-2019)
        11.6.4 Wuhan Institute of Biological Products Pertussis Vaccine Products Offered
        11.6.5 Wuhan Institute of Biological Products Recent Development
    11.7 Changchun Changsheng Life Sciences
        11.7.1 Changchun Changsheng Life Sciences Company Details
        11.7.2 Company Business Overview
        11.7.3 Changchun Changsheng Life Sciences Pertussis Vaccine Sales, Revenue and Gross Margin (2014-2019)
        11.7.4 Changchun Changsheng Life Sciences Pertussis Vaccine Products Offered
        11.7.5 Changchun Changsheng Life Sciences Recent Development

12 Future Forecast
    12.1 Pertussis Vaccine Market Forecast by Regions
        12.1.1 Global Pertussis Vaccine Sales Forecast by Regions 2019-2025
        12.1.2 Global Pertussis Vaccine Revenue Forecast by Regions 2019-2025
    12.2 Pertussis Vaccine Market Forecast by Product
        12.2.1 Global Pertussis Vaccine Sales Forecast by Product 2019-2025
        12.2.2 Global Pertussis Vaccine Revenue Forecast by Product 2019-2025
    12.3 Pertussis Vaccine Market Forecast by End User
    12.4 North America Pertussis Vaccine Forecast
    12.5 Europe Pertussis Vaccine Forecast
    12.6 Asia Pacific Pertussis Vaccine Forecast
    12.7 Central & South America Pertussis Vaccine Forecast
    12.8 Middle East and Africa Pertussis Vaccine Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Pertussis Vaccine Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables and Figures

    Figure Pertussis Vaccine Product Picture
    Table Pertussis Vaccine Market Segments
    Table Key Manufacturers Pertussis Vaccine Covered
    Table Global Pertussis Vaccine Market Size Growth Rate by Product 2019-2025 (K Doses) & (Million US$)
    Figure Global Pertussis Vaccine Sales Market Share by Product 2014-2025
    Figure Whole-cell vaccines Product Picture
    Table Major Manufacturers of Whole-cell vaccines
    Figure Acellular vaccines Product Picture
    Table Major Manufacturers of Acellular vaccines
    Table Global Pertussis Vaccine Market Size Growth Rate by End User 2019-2025 (K Doses)
    Figure Children
    Figure Adults
    Figure Pertussis Vaccine Report Years Considered
    Figure Global Pertussis Vaccine Market Size 2014-2025 (Million US$)
    Figure Global Pertussis Vaccine Sales 2014-2025 (K Doses)
    Table Global Pertussis Vaccine Market Size by Regions 2014-2019 (K Doses) & (Million US$)
    Table Global Pertussis Vaccine Sales by Regions 2014-2019 (K Doses)
    Table Global Pertussis Vaccine Sales Market Share by Regions 2014-2019
    Figure Global Pertussis Vaccine Sales Market Share by Regions 2014-2019
    Figure 2018 Global Pertussis Vaccine Sales Market Share by Regions
    Table Global Pertussis Vaccine Revenue by Regions 2014-2019 (Million US$)
    Table Global Pertussis Vaccine Revenue Market Share by Regions 2014-2019
    Figure Global Pertussis Vaccine Revenue Market Share by Regions 2014-2019
    Figure 2018 Global Pertussis Vaccine Revenue Market Share by Regions
    Table Global Pertussis Vaccine Sales by Manufacturers (2014-2019) (K Doses)
    Table Global Pertussis Vaccine Sales Share by Manufacturers (2014-2019)
    Figure Global Pertussis Vaccine Sales Share by Manufacturers in 2018
    Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Pertussis Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
    Table Pertussis Vaccine Revenue Share by Manufacturers (2014-2019)
    Figure Pertussis Vaccine Value Share by Manufacturers in 2018
    Table Key Manufacturers Pertussis Vaccine Price (2014-2019) (USD/Doses)
    Table Pertussis Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Pertussis Vaccine Product Type
    Table Date of International Manufacturers Enter into Pertussis Vaccine Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Pertussis Vaccine Sales by Product (2014-2019) (K Doses)
    Table Global Pertussis Vaccine Sales Share by Product (2014-2019)
    Figure Global Pertussis Vaccine Sales Market Share by Product (2014-2019)
    Figure Global Pertussis Vaccine Sales Market Share by Product in 2018
    Table Global Pertussis Vaccine Revenue by Product (2014-2019) (Million US$)
    Table Global Pertussis Vaccine Revenue Share by Product (2014-2019)
    Figure Global Pertussis Vaccine Revenue Market Share by Product (2014-2019)
    Figure Global Pertussis Vaccine Revenue Market Share by Product in 2018
    Table Pertussis Vaccine Price by Product 2014-2019 (USD/Doses)
    Table Global Pertussis Vaccine Sales by End User (2014-2019) (K Doses)
    Table Global Pertussis Vaccine Sales Share by End User (2014-2019)
    Figure Global Sales Pertussis Vaccine Market Share by End User (2014-2019)
    Figure Global Sales Pertussis Vaccine Market Share by End User in 2018
    Figure North America Pertussis Vaccine Sales Growth Rate 2014-2019 (K Doses)
    Figure North America Pertussis Vaccine Revenue Growth Rate 2014-2019 (Million US$)
    Table North America Pertussis Vaccine Sales by Countries (2014-2019) (K Doses)
    Table North America Pertussis Vaccine Sales Market Share by Countries (2014-2019)
    Figure 2018 North America Pertussis Vaccine Sales Market Share by Countries
    Table North America Pertussis Vaccine Revenue by Countries (2014-2019) (Million US$)
    Table North America Pertussis Vaccine Revenue Market Share by Countries (2014-2019)
    Figure 2018 North America Pertussis Vaccine Revenue Market Share by Countries
    Figure United States Pertussis Vaccine Sales Growth Rate (2014-2019) (K Doses)
    Figure United States Pertussis Vaccine Revenue Growth Rate (2014-2019) (K Doses)
    Figure Canada Pertussis Vaccine Sales Growth Rate (2014-2019) (K Doses)
    Figure Canada Pertussis Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Mexico Pertussis Vaccine Sales Growth Rate (2014-2019) (K Doses)
    Figure Mexico Pertussis Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Table North America Pertussis Vaccine Sales by Product (2014-2019) (K Doses)
    Table North America Pertussis Vaccine Sales Market Share by Product (2014-2019)
    Figure 2018 North America Pertussis Vaccine Market Share by Product
    Table North America Pertussis Vaccine Sales by End User (2014-2019) (K Doses)
    Table North America Pertussis Vaccine Sales Market Share by End User (2014-2019)
    Figure 2018 North America Pertussis Vaccine Market Share by End User
    Figure Europe Pertussis Vaccine Sales Growth Rate 2014-2019 (K Doses)
    Figure Europe Pertussis Vaccine Revenue Growth Rate 2014-2019 (Million US$)
    Table Europe Pertussis Vaccine Sales by Countries (2014-2019) (K Doses)
    Table Europe Pertussis Vaccine Sales Market Share by Countries (2014-2019)
    Figure 2018 Europe Pertussis Vaccine Sales Market Share by Countries
    Table Europe Pertussis Vaccine Revenue by Countries (2014-2019) (Million US$)
    Table Europe Pertussis Vaccine Revenue Market Share by Countries (2014-2019)
    Figure 2018 Europe Pertussis Vaccine Revenue Market Share by Countries
    Figure Germany Pertussis Vaccine Sales Growth Rate (2014-2019) (K Doses)
    Figure Germany Pertussis Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure France Pertussis Vaccine Sales Growth Rate (2014-2019) (K Doses)
    Figure France Pertussis Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure UK Pertussis Vaccine Sales Growth Rate (2014-2019) (K Doses)
    Figure UK Pertussis Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Italy Pertussis Vaccine Sales Growth Rate (2014-2019) (K Doses)
    Figure Italy Pertussis Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Russia Pertussis Vaccine Sales Growth Rate (2014-2019) (K Doses)
    Figure Russia Pertussis Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Table Europe Pertussis Vaccine Sales by Product (2014-2019) (K Doses)
    Table Europe Pertussis Vaccine Sales Market Share by Product (2014-2019)
    Figure 2018 Europe Pertussis Vaccine Market Share by Product
    Table Europe Pertussis Vaccine Sales by End User (2014-2019) (K Doses)
    Table Europe Pertussis Vaccine Sales Market Share by End User (2014-2019)
    Figure 2018 Europe Pertussis Vaccine Market Share by End User
    Figure Asia Pacific Pertussis Vaccine Sales Growth Rate 2014-2019 (K Doses)
    Figure Asia Pacific Pertussis Vaccine Revenue Growth Rate 2014-2019 (Million US$)
    Table Asia Pacific Pertussis Vaccine Sales by Countries (2014-2019) (K Doses)
    Table Asia Pacific Pertussis Vaccine Sales Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Pertussis Vaccine Sales Market Share by Countries
    Table Asia Pacific Pertussis Vaccine Revenue by Countries (2014-2019) (Million US$)
    Table Asia Pacific Pertussis Vaccine Revenue Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Pertussis Vaccine Revenue Market Share by Countries
    Figure China Pertussis Vaccine Sales Growth Rate (2014-2019) (K Doses)
    Figure China Pertussis Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Japan Pertussis Vaccine Sales Growth Rate (2014-2019) (K Doses)
    Figure Japan Pertussis Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Korea Pertussis Vaccine Sales Growth Rate (2014-2019) (K Doses)
    Figure Korea Pertussis Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure India Pertussis Vaccine Sales Growth Rate (2014-2019) (K Doses)
    Figure India Pertussis Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Australia Pertussis Vaccine Sales Growth Rate (2014-2019) (K Doses)
    Figure Australia Pertussis Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Indonesia Pertussis Vaccine Sales Growth Rate (2014-2019) (K Doses)
    Figure Indonesia Pertussis Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Malaysia Pertussis Vaccine Sales Growth Rate (2014-2019) (K Doses)
    Figure Malaysia Pertussis Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Philippines Pertussis Vaccine Sales Growth Rate (2014-2019) (K Doses)
    Figure Philippines Pertussis Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Thailand Pertussis Vaccine Sales Growth Rate (2014-2019) (K Doses)
    Figure Thailand Pertussis Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Vietnam Pertussis Vaccine Sales Growth Rate (2014-2019) (K Doses)
    Figure Vietnam Pertussis Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Singapore Pertussis Vaccine Sales Growth Rate (2014-2019) (K Doses)
    Figure Singapore Pertussis Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Table Asia Pacific Pertussis Vaccine Sales by Product (2014-2019) (K Doses)
    Table Asia Pacific Pertussis Vaccine Sales Market Share by Product (2014-2019)
    Figure 2018 Asia Pacific Pertussis Vaccine Market Share by Product
    Table Asia Pacific Pertussis Vaccine Sales by End User (2014-2019) (K Doses)
    Table Asia Pacific Pertussis Vaccine Sales Market Share by End User (2014-2019)
    Figure 2018 Asia Pacific Pertussis Vaccine Market Share by End User
    Figure Central & South America Pertussis Vaccine Sales Growth Rate 2014-2019 (K Doses)
    Figure Central & South America Pertussis Vaccine Revenue Growth Rate 2014-2019 (Million US$)
    Table Central & South America Pertussis Vaccine Sales by Countries (2014-2019) (K Doses)
    Table Central & South America Pertussis Vaccine Sales Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Pertussis Vaccine Sales Market Share by Countries
    Table Central & South America Pertussis Vaccine Revenue by Countries (2014-2019) (Million US$)
    Table Central & South America Pertussis Vaccine Revenue Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Pertussis Vaccine Revenue Market Share by Countries
    Figure Brazil Pertussis Vaccine Sales Growth Rate (2014-2019) (K Doses)
    Figure Brazil Pertussis Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Argentina Pertussis Vaccine Sales Growth Rate (2014-2019) (K Doses)
    Figure Argentina Pertussis Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Table Central & South America Pertussis Vaccine Sales by Product (2014-2019) (K Doses)
    Table Central & South America Pertussis Vaccine Sales Market Share by Product (2014-2019)
    Figure 2018 Central & South America Pertussis Vaccine Market Share by Product
    Table Central & South America Pertussis Vaccine Sales by End User (2014-2019) (K Doses)
    Table Central & South America Pertussis Vaccine Sales Market Share by End User (2014-2019)
    Figure 2018 Central & South America Pertussis Vaccine Market Share by End User
    Figure Middle East and Africa Pertussis Vaccine Sales Growth Rate 2014-2019 (K Doses)
    Figure Middle East and Africa Pertussis Vaccine Revenue Growth Rate 2014-2019 (Million US$)
    Table Middle East and Africa Pertussis Vaccine Sales by Countries (2014-2019) (K Doses)
    Table Middle East and Africa Pertussis Vaccine Sales Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Pertussis Vaccine Sales Market Share by Countries
    Table Middle East and Africa Pertussis Vaccine Revenue by Countries (2014-2019) (Million US$)
    Table Middle East and Africa Pertussis Vaccine Revenue Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Pertussis Vaccine Revenue Market Share by Countries
    Figure GCC Countries Pertussis Vaccine Sales Growth Rate (2014-2019) (K Doses)
    Figure GCC Countries Pertussis Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Turkey Pertussis Vaccine Sales Growth Rate (2014-2019) (K Doses)
    Figure Turkey Pertussis Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Egypt Pertussis Vaccine Sales Growth Rate (2014-2019) (K Doses)
    Figure Egypt Pertussis Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure South Africa Pertussis Vaccine Sales Growth Rate (2014-2019) (K Doses)
    Figure South Africa Pertussis Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Table Middle East and Africa Pertussis Vaccine Sales by Product (2014-2019) (K Doses)
    Table Middle East and Africa Pertussis Vaccine Sales Market Share by Product (2014-2019)
    Figure 2018 Middle East and Africa Pertussis Vaccine Market Share by Product
    Table Middle East and Africa Pertussis Vaccine Sales by End User (2014-2019) (K Doses)
    Table Middle East and Africa Pertussis Vaccine Sales Market Share by End User (2014-2019)
    Figure 2018 Middle East and Africa Pertussis Vaccine Market Share by End User
    Table Sanofi Pasteur Company Details
    Table Sanofi Pasteur Pertussis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
    Table Sanofi Pasteur Recent Development
    Table GSK Company Details
    Table GSK Pertussis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
    Table GSK Recent Development
    Table Mitsubishi Tanabe Pharma Company Details
    Table Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
    Table Mitsubishi Tanabe Pharma Recent Development
    Table Astellas Pharma Company Details
    Table Astellas Pharma Pertussis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
    Table Astellas Pharma Recent Development
    Table Minhai Biotechnology Company Details
    Table Minhai Biotechnology Pertussis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
    Table Minhai Biotechnology Recent Development
    Table Wuhan Institute of Biological Products Company Details
    Table Wuhan Institute of Biological Products Pertussis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
    Table Wuhan Institute of Biological Products Recent Development
    Table Changchun Changsheng Life Sciences Company Details
    Table Changchun Changsheng Life Sciences Pertussis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
    Table Changchun Changsheng Life Sciences Recent Development
    Table Global Pertussis Vaccine Sales Forecast by Regions 2019-2025 (K Doses)
    Table Global Pertussis Vaccine Sales Market Share Forecast by Regions 2019-2025
    Table Global Pertussis Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
    Table Global Pertussis Vaccine Revenue Market Share Forecast by Regions 2019-2025
    Table Global Pertussis Vaccine Sales Forecast by Product 2019-2025 (K Doses)
    Table Global Pertussis Vaccine Sales Market Share Forecast by Product 2019-2025
    Table Global Pertussis Vaccine Revenue Forecast by Product 2019-2025 (Million US$)
    Table Global Pertussis Vaccine Revenue Market Share Forecast by Product 2019-2025
    Table Global Pertussis Vaccine Sales Forecast by End User 2019-2025 (K Doses)
    Table Global Pertussis Vaccine Sales Market Share Forecast by End User 2019-2025
    Figure North America Pertussis Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
    Figure North America Pertussis Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Europe Pertussis Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
    Figure Europe Pertussis Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Asia Pacific Pertussis Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
    Figure Asia Pacific Pertussis Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Central & South America Pertussis Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
    Figure Central & South America Pertussis Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Middle East and Africa Pertussis Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
    Figure Middle East and Africa Pertussis Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Table Pertussis Vaccine Value Chain
    Table Pertussis Vaccine Customers List
    Table Pertussis Vaccine Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano String

RELATED REPORTS

China Autogenous Vaccines Market Report Forecast 2021 2027
China Autogenous Vaccines Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-22Z1818
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

Global Flu Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Flu Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

In 2020 the global Flu Vaccine market size was US 5154 million and it is expected to reach US 7293.3 million by the end of 2027 with a CAGR of 4.8 during 20212027.Global Flu Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 20212027.

120 Pages
Type: Report
Code: QYRE-Auto-11H675
Mon Sep 27 00:00:00 UTC 2021

Add to Cart

Global Rabies Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Rabies Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

And in terms of application the largest application is Postexposure Prophylaxis followed by Preexposure Prophylaxis.Market Analysis and Insights Global Rabies Vaccine MarketIn 2020 the global Rabies Vaccine market size was US 877 million and it is expected to reach US 1178 million by the end of 2027 with a CAGR of 4.0 during 20212027.Global Rabies Vaccin.

120 Pages
Type: Report
Code: QYRE-Auto-34M23
Mon Sep 27 00:00:00 UTC 2021

Add to Cart

Global and United States Sulfachloropyridazine Sodium Market Insights Forecast to 2027
Global and United States Sulfachloropyridazine Sodium Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-28M6619
Tue Sep 21 00:00:00 UTC 2021

Add to Cart